<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:34:57Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2734466" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2734466</identifier><datestamp>2009-10-20</datestamp><setSpec>plosone</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2734466</article-id>
      <article-id pub-id-type="pmcid">PMC2734466</article-id>
      <article-id pub-id-type="pmc-uid">2734466</article-id>
      <article-id pub-id-type="pmid">19841671</article-id>
      <article-id pub-id-type="pmid">19841671</article-id>
      <article-id pub-id-type="publisher-id">09-PONE-RA-09495R1</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0006975</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Biochemistry/Macromolecular Assemblies and Machines</subject>
          <subject>Biochemistry/Protein Folding</subject>
          <subject>Biochemistry/Structural Genomics</subject>
          <subject>Genetics and Genomics/Genetics of Disease</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Crystal Structure of the ATPase Domain of the Human AAA+ Protein Paraplegin/SPG7</article-title>
        <alt-title alt-title-type="running-head">Structure of Human Paraplegin</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Karlberg</surname>
            <given-names>Tobias</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van den Berg</surname>
            <given-names>Susanne</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HammarstrÃ¶m</surname>
            <given-names>Martin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sagemark</surname>
            <given-names>Johanna</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Johansson</surname>
            <given-names>Ida</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holmberg-Schiavone</surname>
            <given-names>Lovisa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="author-notes" rid="fn1">
<sup>Â¤</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SchÃ¼ler</surname>
            <given-names>Herwig</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<addr-line>Structural Genomics Consortium, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Gay</surname>
            <given-names>Nick</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">University of Cambridge, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>herwig.schuler@ki.se</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: TK LHS HS. Performed the experiments: TK SvdB MH IJ. Analyzed the data: TK HS. Contributed reagents/materials/analysis tools: JS. Wrote the paper: TK HS.</p>
        </fn>
        <fn id="fn1" fn-type="current-aff">
          <label>Â¤</label>
          <p>Current address: Structural Chemistry Laboratory, AstraZeneca R&amp;D, MÃ¶lndal, Sweden</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
      <volume>4</volume>
      <issue>10</issue>
      <elocation-id>e6975</elocation-id>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>3</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>5</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Karlberg et al.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title/>
          <p>Paraplegin is an <italic>m</italic>-AAA protease of the mitochondrial inner membrane that is linked to hereditary spastic paraplegias. The gene encodes an FtsH-homology protease domain in tandem with an AAA+ homology ATPase domain. The protein is believed to form a hexamer that uses ATPase-driven conformational changes in its AAA-domain to deliver substrate peptides to its protease domain. We present the crystal structure of the AAA-domain of human paraplegin bound to ADP at 2.2 Ã. This enables assignment of the roles of specific side chains within the catalytic cycle, and provides the structural basis for understanding the mechanism of disease mutations.</p>
        </sec>
        <sec>
          <title>Enhanced version</title>
          <p>
<bold>This article can also be viewed as an <ext-link ext-link-type="uri" xlink:href="http://plosone.org/enhanced/pone.0006975/">enhanced version</ext-link> in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in <xref ref-type="supplementary-material" rid="pone.0006975.s002">Text S1</xref>.</bold>
</p>
        </sec>
      </abstract>
      <counts>
        <page-count count="7"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Molecular machines are protein assemblies, often multimeric complexes, that convert chemical energy into mechanical work by undergoing conformational changes in their protein subunits. An ATPase domain, alone or coupled in series, usually forms the basis for these machineries. The AAA+ domain (âATPases associated with diverse cellular activitiesâ and related proteins) is one such module; it is often found as a hexameric ring complex, and couples ATP hydrolysis to activities that involve protein remodeling (reviewed in <xref rid="pone.0006975-Hanson1" ref-type="bibr">[1]</xref>â<xref rid="pone.0006975-Snider1" ref-type="bibr">[4]</xref>). Generally, AAA+ ATPases bind their native targets, unfold them locally by ATP hydrolysis-driven conformational changes, and release the unfolded target for further processing (such as refolding, transport across membranes, or degradation). AAA+ domains are found in all kingdoms of life; in eukaryotes, they are present in the cytosol, in most cellular compartments, as well as associated with membranes. Over 60 classical AAA+ members and an additional number of divergent domains are encoded in the human genome.</p>
      <p>Human paraplegin (SPG7) <xref rid="pone.0006975-Casari1" ref-type="bibr">[5]</xref> is a mitochondrial membrane-associated AAA-domain containing metalloprotease consisting of three homology domains (<xref ref-type="fig" rid="pone-0006975-g001">Figure 1</xref>): The N-terminal FtsH-extracellular domain, which is found in membrane-bound ATP-dependent proteases; the intermediate AAA-domain; and the C-terminal metallopeptidase M41 domain <xref rid="pone.0006975-Juhola1" ref-type="bibr">[6]</xref>. The current state of evidence indicates that the protein forms cylindrical hexamers that insert in the inner mitochondrial membrane such that the FtsH-domains are located in the lumen, and the catalytic domains in the matrix. Paraplegin is implicated in the degradation of proteins that come out misfolded after transport across the mitochondrial membranes, and in cleavage of mitochondrial targeting sequences. Paraplegin function is critically involved in ribosome maturation <xref rid="pone.0006975-Nolden1" ref-type="bibr">[7]</xref>.</p>
      <fig id="pone-0006975-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0006975.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Domain arrangement and sequence comparison of paraplegin/SPG7 and related AAA+ proteins.</title>
          <p>A. Domain arrangement of paraplegin, FtsH, VCP, and spastin. Homologies included are the FtsH extracellular (Pfam entry PF36480), AAA+ (PF00004), metallopeptidase M41 (PF01434), Cell division protein-48 (CDC48) N-terminal (PF02359), CDC48-2 (PF02933), and microtubule interacting and transport (MIT; PF04212) domains. B. Sequence alignment of the ATPase domains of paraplegin and related proteins to illustrate the positions of conserved residues. Residue numbering and secondary structural elements are indicated for paraplegin (PDB entry 2qz4) above the alignment. Walker A and B, and Sensor 1 and 2 motifs, the arginine residue predicted to act as an arginine finger, as well as the pore loop are indicated below the alignment. Indicated by green asterisks are HSP disease related positions. Sequences shown are human paraplegin/SPG7 (residues 305â565; PDB entry 2qz4; gene identification code 116242796). <italic>Thermus thermophilus</italic> FtsH (126â624; 2dhr; gi:8051696), <italic>Thermotoga maritima</italic> FtsH (147â610; 2cea; gi:15643346), human p97/VCP (116â417; gi:112818458), and human spastin/SPG4 (114â437; gi:11875211).</p>
        </caption>
        <graphic xlink:href="pone.0006975.g001"/>
      </fig>
      <p>Paraplegin was originally discovered and named for its involvement in hereditary spastic paraplegias (HSP) <xref rid="pone.0006975-Casari1" ref-type="bibr">[5]</xref>. These are heterogeneous syndromes most commonly manifested in progressive spasticity and weakness of the lower limbs. At present, around 40 genes have been recognized to contribute to HSP <xref rid="pone.0006975-Salinas1" ref-type="bibr">[8]</xref>. HSP-related mutations in the SPG7 gene cause axonal degeneration (reviewed in <xref rid="pone.0006975-Rugarli1" ref-type="bibr">[9]</xref>). Nonsense loss-of-function mutations are prevalent, but disease-linked amino acid replacements in the AAA-domain have also been identified.</p>
      <p>Here, the crystal structure of the AAA-domain of human paraplegin is presented in complex with ADP. The overall fold and the nucleotide binding site are described. We outline the side chains that, by homology with FtsH, are implicated in hexamer formation, substrate binding, and chemomechanical coupling. Finally, we discuss the putative roles of disease-related residues.</p>
    </sec>
    <sec sec-type="materials|methods" id="s2">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Protein expression and purification</title>
        <p>Human SPG7 cDNA was obtained from Deutsches Ressourcenzentrum fÃ¼r Genomforschung (accession no. BC036104). The sequence encoding paraplegin residues 305â565 was amplified by PCR and inserted into pNIC28-Bsa4 by ligation independent cloning. The expression construct included a TEV protease-cleavable N-terminal hexahistidine tag. Protein expression in <italic>Escherichia coli</italic> strain BL21(DE3) gold pRARE2 was done in a LEX system (Harbinger Biotechnology and Engineering) using Terrific Broth medium supplemented with 8 g/l glycerol, 34 Âµg/ml chloramphenicol and 50 Âµg/ml kanamycin, induction with 0.5 mM IPTG, and over night culture at 18Â°C. Cell pellets were resuspended in 50 mM HEPES pH 7.8, 500 mM NaCl, 10 mM imidazole, 10% glycerol, 0.5 mM TCEP, and Complete EDTA-free Protease Inhibitor (Roche Biosciences). Cells were lysed by a freeze/thaw cycle followed by addition of benzonase (Novagen) and sonication (Sonics VibraCell). Lysates were centrifuged at 49,000 g for 20 min at 4Â°C. The supernatants were decanted and filtered.</p>
        <p>Filtered lysates of cells expressing paraplegin<sup>305â565</sup> were loaded onto HiTrap Chelating HP columns (GE Healthcare) in buffer 1 (30 mM HEPES pH 7.5, 500 mM NaCl, 10 mM imidazole, 10% glycerol, and 0.5 mM TCEP). The columns were washed with buffer 1 containing 25 mM imidazole. Bound protein was eluted with buffer 1 containing 500 mM imidazole. The protein showed a strong tendency to precipitate in the presence of imidazole. The sample was filtered and loaded onto a HiLoad 16/60 Superdex-200 column (GE Healthcare) pre-equilibrated with buffer 2 (50 mM sodium citrate pH 5.5, 100 mM ammonium sulfate, 10% glycerol, 2 mM TCEP). Fractions containing target protein were pooled, and the N-terminal hexahistidine tag was removed by incubation with His-tagged TEV protease (molar ratio 50â¶1) over night at room temperature, followed by passage over a 1 ml HisTrap HP column in buffer 1 without imidazole (<xref ref-type="fig" rid="pone-0006975-g002">Figure 2A</xref>). Purified protein was concentrated using Vivaspin (Sartorius) centrifugal concentrators. Aliquots were flash-frozen and stored at â80Â°C. All proteins were verified by time-of-flight mass spectrometry analysis.</p>
        <fig id="pone-0006975-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0006975.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Purification and crystallization of paraplegin<sup>305â565</sup>.</title>
            <p>A. Coomassie-stained SDS-polyacrylamide gel showing the purity of crude paraplegin<sup>305â565</sup> after TEV-cleavage (left lane; red asterisk, hexahistidine-tagged protein; black asterisk, cleaved protein), and after the final purification step (right lane). B. Example of crystals grown under the conditions that yielded diffraction data.</p>
          </caption>
          <graphic xlink:href="pone.0006975.g002"/>
        </fig>
      </sec>
      <sec id="s2b">
        <title>Crystallization, data collection, structure solution and refinement</title>
        <p>Crystals of paraplegin<sup>305â565</sup> in complex with ADP were obtained by vapor diffusion in sitting drops incubated at 20Â°C by mixing equal amounts of protein solution at (20.0 mg/ml, including 2.5 mM ATP and 2.5 mM MgCl<sub>2</sub>) and reservoir solution containing 25% PEG-3350, 100 mM Bis-Tris pH 6.5, 200 mM ammonium acetate (<xref ref-type="fig" rid="pone-0006975-g002">Figure 2B</xref>). Crystals appeared after three days and continued to grow for one more week to reach their maximal size (0.15 mmÃ0.06 mmÃ0.06 mm). Reservoir solution supplemented with 15% glycerol was added directly to the drop, and crystals were mounted and flash-frozen in liquid nitrogen. Diffraction data to 2.2 Ã resolution were collected at ESRF Grenoble, France (beamline ID 14-2). Data were integrated and scaled using XDS <xref rid="pone.0006975-Kabsch1" ref-type="bibr">[10]</xref>; one molecule was found in the asymmetric unit. The structure was solved by Molrep <xref rid="pone.0006975-Vagin1" ref-type="bibr">[11]</xref> using the structure of <italic>T. maritima</italic> FtsH (PDB entry 2ce7) as a search model. The structure was refined with RefMac5 <xref rid="pone.0006975-Murshudov1" ref-type="bibr">[12]</xref>. Restrained refinement using three TLS groups was performed using the TLSMD server <xref rid="pone.0006975-Painter1" ref-type="bibr">[13]</xref>. Model building was done using Coot <xref rid="pone.0006975-Emsley1" ref-type="bibr">[14]</xref>. For further details, see <xref ref-type="table" rid="pone-0006975-t001">Table 1</xref>. Geometry of the models was analyzed with Molprobity <xref rid="pone.0006975-Lovell1" ref-type="bibr">[15]</xref>. Sequence alignments were obtained using ESPript <xref rid="pone.0006975-Gouet1" ref-type="bibr">[16]</xref>.</p>
        <table-wrap id="pone-0006975-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0006975.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Paraplegin crystal structure: Data collection and refinement statistics.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0006975-t001-1" xlink:href="pone.0006975.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Structure</td>
                  <td align="left" rowspan="1" colspan="1">Paraplegin</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ligand</td>
                  <td align="left" rowspan="1" colspan="1">ADP</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PDB entry</td>
                  <td align="left" rowspan="1" colspan="1">2QZ4</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Beamline</td>
                  <td align="left" rowspan="1" colspan="1">ID 14-2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Wavelength (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">0.9330</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Space group</td>
                  <td align="left" rowspan="1" colspan="1">P4<sub>3</sub>22</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">Cell dimensions</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">57.2, 57.2, 157.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Î±, Î², Î³ (Â°)</td>
                  <td align="left" rowspan="1" colspan="1">90.0, 90.0, 90.0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Resolution (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">40.0â2.2 (2.3â2.2)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">R<sub>sym</sub>
</td>
                  <td align="left" rowspan="1" colspan="1">0.069 (0.203)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">I/(ÏI)</td>
                  <td align="left" rowspan="1" colspan="1">23.7 (7.2)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Completeness (%)</td>
                  <td align="left" rowspan="1" colspan="1">99.1 (62.7)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Redundancy</td>
                  <td align="left" rowspan="1" colspan="1">10.6 (4.7)</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
<underline>Refinement</underline>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Resolution (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">39.1 â 2.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No. reflections</td>
                  <td align="left" rowspan="1" colspan="1">12529</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">R<sub>work</sub>
<xref ref-type="table-fn" rid="nt102">â </xref>/R<sub>free</sub>
<xref ref-type="table-fn" rid="nt103">â¡</xref>
</td>
                  <td align="left" rowspan="1" colspan="1">0.209/0.269</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">No. atoms</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein</td>
                  <td align="left" rowspan="1" colspan="1">1680</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ligands</td>
                  <td align="left" rowspan="1" colspan="1">27</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Water</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
<italic>B</italic>-factors (Ã<sup>2</sup>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein</td>
                  <td align="left" rowspan="1" colspan="1">56.1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ligands</td>
                  <td align="left" rowspan="1" colspan="1">40.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Water</td>
                  <td align="left" rowspan="1" colspan="1">55.6</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">R.m.s. deviations</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Bond lengths (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">0.015</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Bond angles (Â°)</td>
                  <td align="left" rowspan="1" colspan="1">1.6</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">Ramachandran plot</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Favored regions (%)</td>
                  <td align="left" rowspan="1" colspan="1">94.9</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Disallowed regions (%)</td>
                  <td align="left" rowspan="1" colspan="1">0.9</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Values for the highest resolution shell are shown in parentheses.</p>
            </fn>
            <fn id="nt102">
              <label>â </label>
              <p>R<sub>work</sub> is defined as Î£||F<sub>obs</sub>|â|F<sub>calc</sub>||/Î£ |F<sub>obs</sub>|, where F<sub>obs</sub> and F<sub>calc</sub> are observed and calculated structure-factor amplitudes, respectively.</p>
            </fn>
            <fn id="nt103">
              <label>â¡</label>
              <p>R<sub>free</sub> is the R factor for the test set (5â10% of the data).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For further details, please refer to <ext-link ext-link-type="uri" xlink:href="http://www.thesgc.com/SGC-WebPages/StructureDescription/MM-v2.php?pdb=2QZ4">http://www.thesgc.com/SGC-WebPages/StructureDescription/MM-v2.php?pdb=2QZ4</ext-link>.</p>
      </sec>
      <sec id="s2c">
        <title>Data deposition</title>
        <p>The atomic coordinates and structure factors have been deposited with the Protein Data Bank, <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link> (PDB entry code 2qz4).</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results and Discussion</title>
      <p>We purified recombinant human paraplegin including residues 305â565 (corresponding to the ATPase domain; <xref ref-type="fig" rid="pone-0006975-g001">Figure 1A</xref>) in the absence of excess nucleotide. Elution profiles after gel filtration suggested the presence of a minor amount of higher molecular weight complex, while the majority of the protein eluted as a monomer. We determined the crystal structure of this protein to a resolution of 2.2 Ã. The protein crystallized with one monomer in the asymmetric unit, and ADP was bound in the nucleotide binding site. The structure shows the typical AAA+ domain consisting of a five-stranded parallel Î²-sheet flanked by two Î±-helices on each side, together with a carboxy-terminal bundle of four antiparallel Î±-helices (<xref ref-type="fig" rid="pone-0006975-g003">Figure 3</xref> and Supplementary <xref ref-type="supplementary-material" rid="pone.0006975.s001">Datapack S1</xref>). The refined structure contains residues 305â565, with the exception of loop residues Arg 333 â Gly 338, Asp 411 â Glu 429, Ala 532 â Ser 539, and Ser 560 â Lys 565, for which no density could be observed.</p>
      <fig id="pone-0006975-g003" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0006975.g003</object-id>
        <label>Figure 3</label>
        <caption>
          <title>Overview of the paraplegin ATPase domain structure.</title>
          <p>A. Schematic representation of the crystal structure of a monomer of paraplegin<sup>305â565</sup> with bound ADP. Sequence motifs indicated in the sequence alignment in <xref ref-type="fig" rid="pone-0006975-g001">Figure 1</xref> have been mapped onto the structure. The positions of disease-related residues are labeled in blue. B. Electrostatic surface representation of paraplegin<sup>305â565</sup> illustrating the nucleotide binding cleft.</p>
        </caption>
        <graphic xlink:href="pone.0006975.g003"/>
      </fig>
      <sec id="s3a">
        <title>Nucleotide binding site and the conserved motifs</title>
        <p>The nucleotide binding pocket is located at the interface between the Î²-sheet and the Î±-helical bundle (<xref ref-type="fig" rid="pone-0006975-g003">Figure 3</xref>). Despite high concentrations of ATP and Mg<sup>2+</sup> during crystallization, ADP was clearly seen in the electron density, and as in previously determined FtsH structures <xref rid="pone.0006975-Niwa1" ref-type="bibr">[17]</xref>, density for a magnesium ion was not observed. ADP interacts with side chains from both the amino-terminal part of the AAA-domain and the carboxy-terminal Î±-helical bundle (<xref ref-type="fig" rid="pone-0006975-g004">Figure 4</xref> and Supplementary <xref ref-type="supplementary-material" rid="pone.0006975.s001">Datapack S1</xref>).</p>
        <fig id="pone-0006975-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0006975.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>The nucleotide binding site of paraplegin.</title>
            <p>Details of side chain interactions with ADP.</p>
          </caption>
          <graphic xlink:href="pone.0006975.g004"/>
        </fig>
        <p>The conserved motifs of AAA+ domains are located in the proximity of the nucleotide binding cleft (<xref ref-type="fig" rid="pone-0006975-g003">Figure 3</xref>). The conserved P-loop in the Walker A motif (GxxGxGK(T/S); residues Gly 350 â Thr 356), is central in binding the Î²âphosphate of ADP through hydrogen bonding interactions with the backbone nitrogens of residues 352 â 356, the Lys 355 and Thr 356 side chains, and a water molecule (<xref ref-type="fig" rid="pone-0006975-g004">Figure 4</xref>). The Î±-phosphate binds to the backbone nitrogen of Leu 357 and a water molecule. The two hydroxyls of the ribose moiety hydrogen bond with three water molecules and the ribose 4â²-oxygen hydrogen bonds with the Ala 519 backbone amide. The adenine base is stacked between the hydrophobic side chains of Leu 357 and Ile 448, and hydrogen bonds with the His 492 side chain, the backbone amide and oxygen of Ala 312, and two water molecules.</p>
        <p>The side chains of Lys 355 and Thr 356 in Walker A motif make particularly important contributions to Î²-phosphate binding (<xref ref-type="fig" rid="pone-0006975-g004">Figure 4</xref>). Mutational analysis of the p97/VCP lysine residue corresponding to paraplegin Lys 355 shows that the side chain is essential for ATP hydrolysis <xref rid="pone.0006975-Briggs1" ref-type="bibr">[18]</xref>. Interestingly, in a subset of AAA+ proteins, the Ser/Thr residue of the P-loop is replaced by an asparagine.</p>
        <p>The Walker B motif Ile 404 â Glu 409 (IVYIDE) located to Î²-strand 3 is highly conserved among AAA+ proteins. The acidic side chains in this motif generally coordinate a magnesium ion that activates a water molecule for nucleophilic attack on the ATP Î³-phosphate.</p>
        <p>Sequence Ser 454 â Asn 456 corresponds to the AAA+ Sensor 1 motif (STN). In FtsH, the asparagine is situated at the interface between the ATPase domain and the protease domain, interacting with the Î³-phosphate of ADPNP <xref rid="pone.0006975-Karata1" ref-type="bibr">[19]</xref>, <xref rid="pone.0006975-Suno1" ref-type="bibr">[20]</xref>. This sensor asparagine is a predicted key residue in ATP hydrolysis <xref rid="pone.0006975-Zhang1" ref-type="bibr">[21]</xref>. The corresponding Asn 456 side chain of paraplegin contacts the Î²-phosphate by a water-mediated interaction.</p>
        <p>The Sensor 2 motif Gly 518 - Asp 520 (GAD) couples the state of nucleotide hydrolysis to the oligomerization state. Sequence alignments suggest that the sensor 2 arginine is mutually exclusive with the second Arg near the arginine finger (Arg 467 â Arg 470; RPGR). Thus AAA+ domains contain either one Arg at the C-terminus of Î±5 and the sequence GARx at the N-terminal end of Î±8 (as in e.g. HslU, RuvB and DnaA), or the sequences RxxR and xGAD/E (as in e.g. paraplegin, FtsH and p97) <xref rid="pone.0006975-Ogura1" ref-type="bibr">[22]</xref>.</p>
      </sec>
      <sec id="s3b">
        <title>Role of the alpha-helical bundle</title>
        <p>The carboxy-terminal Î±-helical bundle domain is present in essentially all known AAA+ ATPases <xref rid="pone.0006975-Ammelburg1" ref-type="bibr">[23]</xref>. Together, the helical bundle and the larger N-terminal section of the ATPase domain enclose the nucleotide binding cleft (<xref ref-type="fig" rid="pone-0006975-g004">Figure 4</xref>). Comparison of different AAA+ domain structures shows that the spatial arrangement of the Î±âhelical bundle relative to the N-terminal section of the ATPase domain can vary considerably. Superposition of the N-terminal section of the paraplegin ATPase domain with the corresponding domain of <italic>Thermus thermophilus</italic> FtsH (1iy1) reveals a difference of up to 35 degrees between individual corresponding helices of the Î±-helical bundle. This reflects the mobility of the linker between these domains and shows their potential role in closure of the ATP binding cleft. Although there is no correlation between cleft closure and the state of ATP hydrolysis in the AAA+ domain structures solved to date, the binding of ATP and release of ADP most likely have an effect on the spatial arrangement of the bundle, which in turn could affect the protease domain.</p>
      </sec>
      <sec id="s3c">
        <title>Closest structural homologues</title>
        <p>A structural homology search using the Dali server <xref rid="pone.0006975-Holm1" ref-type="bibr">[24]</xref> reveals that, overall, our structure is most similar to structures of bacterial FtsH (<italic>Thermotoga maritima</italic>, 2cea, 2ce7; <italic>Helicobacter pylori</italic>, 2r65; <italic>T. thermophilus</italic>, 2dhr, 1iy0; <italic>Escherichia coli</italic>, 1lv7), p97/VCP (in particular the D2 subunit; 3cf0), human fidgetin-like protein-1 (3d8b) and the human VPS4/SKD1 ATPase (1xwi). Pairwise superposition of the CÎ±-positions within the AAA+ domains of these structures gives rms differences between 1.7 and 2.8 Ã. The structures of the closest paraplegin homologs are those of bacterial FtsH <xref rid="pone.0006975-Niwa1" ref-type="bibr">[17]</xref>, <xref rid="pone.0006975-Bieniossek1" ref-type="bibr">[25]</xref>, which are 53% identical and &gt;70% similar on the protein sequence level.</p>
        <p>FtsH, as paraplegin, forms hexamers. The FtsH AAA-domain has previously been determined as either a monomer (1lv7, 2dhr) or a monomer arranged along a 6<sub>5</sub>-screw axis <xref rid="pone.0006975-Niwa1" ref-type="bibr">[17]</xref>, while the AAA-domain and the protease domain in tandem crystallized as a hexameric double donut, with the AAA-domain ring overlying the protease ring <xref rid="pone.0006975-Suno1" ref-type="bibr">[20]</xref>, <xref rid="pone.0006975-Bieniossek1" ref-type="bibr">[25]</xref>. The upper AAA-ring is not flat in either of these structures; rather, the monomers are staggered in either 2-fold or 3-fold symmetry, which has been proposed to reflect post-hydrolysis conformations <xref rid="pone.0006975-Suno1" ref-type="bibr">[20]</xref>, <xref rid="pone.0006975-Bieniossek1" ref-type="bibr">[25]</xref>. Collectively, these results show that the protease domain makes a large contribution to intermonomer contacts, and suggest that the ATPase domains have a degree of flexibility also within the context of the ring.</p>
      </sec>
      <sec id="s3d">
        <title>Intermonomer contacts and progressive ATP hydrolysis</title>
        <p>Given the high degree of similarity between paraplegin and FtsH, superposition of our paraplegin AAA-domain structure with the hexameric ring structures of FtsH (2dhr; 1iy1) can reveal common mechanism as well as distinct properties of paraplegin. This analysis shows that in the paraplegin hexamer, the N-terminus and the C-terminal Î±-helical bundle are expected at high radius, while the segment between Î²2 and Î±3 are predicted to lie near the central pore (<xref ref-type="fig" rid="pone-0006975-g005">Figure 5</xref>). The Î±-helical bundle has a threefold role during the chemo-mechanical cycle: 1. A conserved arginine at the N-terminal end of the bundle has been suggested to act as an arginine finger, extending into the active site of the neighboring subunit within the ring and stabilizing the charge developing during the transition state of ATP hydrolysis <xref rid="pone.0006975-Karata1" ref-type="bibr">[19]</xref>, <xref rid="pone.0006975-Ogura1" ref-type="bibr">[22]</xref>. In paraplegin, Arg 470 is positioned to act as an arginine finger. 2. As detailed above, sensor 2 motif (at the N-terminus of Î±7) is likely involved in coupling conformational changes resulting from ATP hydrolysis to the neighbor monomer within the AAA-ring. 3. The bundle is positioned to couple conformational changes resulting from ATP hydrolysis to the underlying protease ring.</p>
        <fig id="pone-0006975-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0006975.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Model of the paraplegin hexamer.</title>
            <p>A. The hexameric structure of paraplegin<sup>305â565</sup> was modelled by aligning our crystal structure (blue) with each monomer within the <italic>T. thermophilus</italic> FtsH hexamer crystal structure (2dhr; orange). The outline of one monomer is indicated by grey shading, and the N- and C-termini of another monomer are indicated. The boxed area is expanded in panel B. B. Close-up of the region around the pore loops and the monomer interface around the nucleotide binding site. The hydrophobic pore loop residue Phe228 of FtsH, implicated in substrate binding, is shown in green, and the corresponding paraplegin residue Ile832 is shown in purple. Paraplegin Arg470, shown in red, is a putative arginine finger that activates ATP hydrolysis in the neighbor monomer following a conformational change in the ring structure.</p>
          </caption>
          <graphic xlink:href="pone.0006975.g005"/>
        </fig>
      </sec>
      <sec id="s3e">
        <title>Substrate binding in the central pore of the hexamer</title>
        <p>The residues at the N-terminus of Î±-helix 3 form the so-called pore loop of the ATPase domain. In the hexamer structure this pore mediates access to the catalytic residues of the peptidase domain <xref rid="pone.0006975-Suno1" ref-type="bibr">[20]</xref>. Mutational analysis of FtsH and ClpX has shown that a bulky apolar residue at position 229 and a glycine at position 231 are essential for substrate-stimulated ATP hydrolysis as well as for substrate degradation <xref rid="pone.0006975-YamadaInagawa1" ref-type="bibr">[26]</xref>, <xref rid="pone.0006975-Martin1" ref-type="bibr">[27]</xref>. Inspection of the structure suggests that the bulky pore side chains and the nucleotide phosphate tail are mutually connected through the Walker B motif. The pore loop of the paraplegin AAA-domain contains the sequence Ile 382 â Gly 384 (IGG), and alignment of our structure with the FtsH hexamer show that the Ile 382 side chains of paraplegin line the central pore in a similar fashion as the Phe 229 side chains of FtsH (<xref ref-type="fig" rid="pone-0006975-g005">Figure 5</xref>). Most AAA+ proteins have aromatic side chains in this position, but paraplegin shares the isoleucine with the LON proteases and the D1 AAA-domain of p97. The residue at this position is an important determinant of substrate specificity <xref rid="pone.0006975-Martin1" ref-type="bibr">[27]</xref>.</p>
      </sec>
      <sec id="s3f">
        <title>Roles of residues involved in hereditary spastic paraplegia</title>
        <p>Most of the known disease mutations in the SPG7 gene lead to premature termination or map to the metallopeptidase domain. Some mutations, however, have been identified in the AAA+ domain, and surprisingly, they all map to the C-terminal Î±-helical bundle (<xref ref-type="fig" rid="pone-0006975-g003">Figure 3A</xref>, <xref ref-type="fig" rid="pone-0006975-g001">Figure 1B</xref> and Supplementary <xref ref-type="supplementary-material" rid="pone.0006975.s001">Datapack S1</xref>). The positions of these disease mutations will be discussed in the following paragraphs.</p>
        <p>A three-residue deletion (Î485â487) in the N-terminal end of Î±-helix 5 <xref rid="pone.0006975-Brugman1" ref-type="bibr">[28]</xref> would shorten the helix by one helical turn. In our structure, the arginine side chains make contacts with the adjacent helix-6 and the turn following it, while the glutamate carboxyl hydrogen bonds with the backbone amide of Gly 313 and with the His 315 side chain. These interactions are critical because they both stabilize the Î±-helical bundle and couple it to the N-terminus, and we predict that the Î485 â 487 mutant leads to considerable destabilization of the overall structure of the AAA-domain.</p>
        <p>The A510V mutation <xref rid="pone.0006975-Brugman1" ref-type="bibr">[28]</xref>â<xref rid="pone.0006975-Elleuch1" ref-type="bibr">[30]</xref> maps to the C-terminal end of Î±-helix 6. The Ala 510 side chain lies on the buried surface of Î±6 that faces Î±5, and it is conceivable that a valine side chain in this position would disturb the hydrophobic core interactions in the helical bundle by its larger volume. In addition, it would possibly clash with the Arg 486 side chain discussed above.</p>
        <p>The F545L <xref rid="pone.0006975-Elleuch1" ref-type="bibr">[30]</xref> and E546K <xref rid="pone.0006975-Arnoldi1" ref-type="bibr">[31]</xref> mutations, at the N-terminal end of Î±-helix 8, are more elusive. Phe 545 is involved in the hydrophobic core of the Î±-helical bundle, but although the side chain does not form stacking interactions with other aromatic side chains in the vicinity, the Leu side chain in position 545 still causes the disease phenotype. A possible explanation for this is that, similar to the A510V mutation, the change in side chain volume might significantly destabilize the hydrophobic core of this minidomain. Glu 546 is situated on the outward facing surface of Î±8, and its role in disease might be explained by a possible disturbance of intermonomer contacts, by removal of the small acidic patch formed together with Glu 550, at some stage during the conformational cycle of the hexamer ring.</p>
        <p>In summary, the disease mutations point to the important role of the Câterminal Î±-helical bundle of the AAA-domain, which is implicated in coupling the state of ATP hydrolysis to both the neighboring monomer within the ring, and the protease domain in the underlying ring. It is surprising that no disease mutations in the sites that are essential for ATP binding and hydrolysis have been identified. AAA+ proteins have ATPase activities that are orders of magnitude lower than other NTPases that feature the same conserved motifs. Thus possibly <italic>in vivo</italic>, ATPase-deficient paraplegin mutants are efficient enough to prevent the disease phenotype as long as the integrity of the pore loops and the conformational coupling between monomers and between the rings is maintained. Such mutants would be able to âratchetâ substrates through the pore and feed them to the peptidase with reduced ATPase activity, and thereby maintain the most important functions of paraplegin. However, disease mutations in the pore loops have not been identified to date. Paraplegin deficient mice develop progressive motor impairment, but are viable and live over 2 years <xref rid="pone.0006975-Ferreirinha1" ref-type="bibr">[32]</xref>. Thus paraplegin function is at least partially redundant, and its loss might be in part compensated for by related proteins. Candidate proteins are the paraplegin-like protein AGF3L2, which is capable of hetero-oligomer formation with paraplegin <xref rid="pone.0006975-Atorino1" ref-type="bibr">[33]</xref>, <xref rid="pone.0006975-Koppen1" ref-type="bibr">[34]</xref>, and the presenilin-associated metalloprotease YME1L1.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="s4">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0006975.s001">
        <label>Datapack S1</label>
        <caption>
          <p>Standalone iSee datapack - contains the enhanced version of this article for use offline. This file can be opened using free software available for download at <ext-link ext-link-type="uri" xlink:href="http://www.molsoft.com/icm_browser.html">http://www.molsoft.com/icm_browser.html</ext-link>.</p>
          <p>(ICB)</p>
        </caption>
        <media xlink:href="pone.0006975.s001.icb">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0006975.s002">
        <label>Text S1</label>
        <caption>
          <p>Instructions for installation and use of the required web plugin (to access the online enhanced version of this article).</p>
          <p>(PDF)</p>
        </caption>
        <media xlink:href="pone.0006975.s002.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We gratefully acknowledge the staff of the ESRF (Grenoble, France) synchrotron radiation facility. We thank Andreas SchÃ¼ler for help with figure preparation, and Wen Wha Lee (SGC, Oxford University) for assistance in the generation of the iSee datapack for the online version of this article.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding: </bold>The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck &amp; Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="pone.0006975-Hanson1">
        <label>1</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanson</surname><given-names>PI</given-names></name><name><surname>Whiteheart</surname><given-names>SW</given-names></name></person-group>
<year>2005</year>
<article-title>AAA+ proteins: Have engine, will work.</article-title>
<source>Nature Reviews Molecular Cell Biology</source>
<volume>6</volume>
<fpage>519</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">16072036</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Erzberger1">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Erzberger</surname><given-names>JP</given-names></name><name><surname>Berger</surname><given-names>JM</given-names></name></person-group>
<year>2006</year>
<article-title>Evolutionary relationships and structural mechanisms of AAA plus proteins.</article-title>
<source>Annual Review of Biophysics and Biomolecular Structure</source>
<volume>35</volume>
<fpage>93</fpage>
<lpage>114</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-White1">
        <label>3</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>White</surname><given-names>SR</given-names></name><name><surname>Lauring</surname><given-names>B</given-names></name></person-group>
<year>2007</year>
<article-title>AAA+ ATPases: Achieving diversity of function with conserved machinery.</article-title>
<source>Traffic</source>
<volume>8</volume>
<fpage>1657</fpage>
<lpage>1667</lpage>
<pub-id pub-id-type="pmid">17897320</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Snider1">
        <label>4</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snider</surname><given-names>J</given-names></name><name><surname>Thibault</surname><given-names>G</given-names></name><name><surname>Houry</surname><given-names>WA</given-names></name></person-group>
<year>2008</year>
<article-title>The AAA plus superfamily of functionally diverse proteins.</article-title>
<source>Genome Biology</source>
<volume>9</volume>
</element-citation>
      </ref>
      <ref id="pone.0006975-Casari1">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casari</surname><given-names>G</given-names></name><name><surname>De Fusco</surname><given-names>M</given-names></name><name><surname>Ciarmatori</surname><given-names>S</given-names></name><name><surname>Zeviani</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>M</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.</article-title>
<source>Cell</source>
<volume>93</volume>
<fpage>973</fpage>
<lpage>983</lpage>
<pub-id pub-id-type="pmid">9635427</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Juhola1">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Juhola</surname><given-names>MK</given-names></name><name><surname>Shah</surname><given-names>ZH</given-names></name><name><surname>Grivell</surname><given-names>LA</given-names></name><name><surname>Jacobs</surname><given-names>HT</given-names></name></person-group>
<year>2000</year>
<article-title>The mitochondrial inner membrane AAA metalloprotease family in metazoans.</article-title>
<source>Febs Letters</source>
<volume>481</volume>
<fpage>91</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">10996302</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Nolden1">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolden</surname><given-names>M</given-names></name><name><surname>Ehses</surname><given-names>S</given-names></name><name><surname>Koppen</surname><given-names>M</given-names></name><name><surname>Bernacchia</surname><given-names>A</given-names></name><name><surname>Rugarli</surname><given-names>EI</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria.</article-title>
<source>Cell</source>
<volume>123</volume>
<fpage>277</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="pmid">16239145</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Salinas1">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salinas</surname><given-names>S</given-names></name><name><surname>Proukakis</surname><given-names>C</given-names></name><name><surname>Crosby</surname><given-names>A</given-names></name><name><surname>Warner</surname><given-names>TT</given-names></name></person-group>
<year>2008</year>
<article-title>Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.</article-title>
<source>Lancet Neurology</source>
<volume>7</volume>
<fpage>1127</fpage>
<lpage>1138</lpage>
<pub-id pub-id-type="pmid">19007737</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Rugarli1">
        <label>9</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rugarli</surname><given-names>EI</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group>
<year>2006</year>
<article-title>Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia.</article-title>
<source>Trends in Molecular Medicine</source>
<volume>12</volume>
<fpage>262</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">16647881</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Kabsch1">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name></person-group>
<year>1993</year>
<article-title>Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants.</article-title>
<source>Journal of Applied Crystallography</source>
<volume>26</volume>
<fpage>795</fpage>
<lpage>800</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Vagin1">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Teplyakov</surname><given-names>A</given-names></name></person-group>
<year>2000</year>
<article-title>An approach to multi-copy search in molecular replacement.</article-title>
<source>Acta Crystallographica D Biological Crystallography</source>
<volume>56</volume>
<fpage>1622</fpage>
<lpage>1624</lpage>
<pub-id pub-id-type="pmid">11092928</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Murshudov1">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group>
<year>1997</year>
<article-title>Refinement of macromolecular structures by the maximum-likelihood method.</article-title>
<source>Acta Crystallographica D Biological Crystallography</source>
<volume>53</volume>
<fpage>240</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="pmid">15299926</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Painter1">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Painter</surname><given-names>J</given-names></name><name><surname>Merritt</surname><given-names>EA</given-names></name></person-group>
<year>2006</year>
<article-title>TLSMD web server for the generation of multi-group TLS models.</article-title>
<source>Journal of Applied Crystallography</source>
<volume>39</volume>
<fpage>109</fpage>
<lpage>111</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Emsley1">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group>
<year>2004</year>
<article-title>Coot: model-building tools for molecular graphics.</article-title>
<source>Acta Crystallographica D Biological Crystallography</source>
<volume>60</volume>
<fpage>2126</fpage>
<lpage>2132</lpage>
<pub-id pub-id-type="pmid">15572765</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Lovell1">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lovell</surname><given-names>SC</given-names></name><name><surname>Davis</surname><given-names>IW</given-names></name><name><surname>Adrendall</surname><given-names>WB</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Word</surname><given-names>JM</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Structure validation by C alpha geometry: phi,psi and C beta deviation.</article-title>
<source>Proteins-Structure Function and Genetics</source>
<volume>50</volume>
<fpage>437</fpage>
<lpage>450</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Gouet1">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gouet</surname><given-names>P</given-names></name><name><surname>Courcelle</surname><given-names>E</given-names></name><name><surname>Stuart</surname><given-names>DI</given-names></name><name><surname>Metoz</surname><given-names>F</given-names></name></person-group>
<year>1999</year>
<article-title>ESPript: analysis of multiple sequence alignments in PostScript.</article-title>
<source>Bioinformatics</source>
<volume>15</volume>
<fpage>305</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="pmid">10320398</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Niwa1">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niwa</surname><given-names>H</given-names></name><name><surname>Tsuchiya</surname><given-names>D</given-names></name><name><surname>Makyio</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Morikawa</surname><given-names>K</given-names></name></person-group>
<year>2002</year>
<article-title>Hexameric ring structure of the ATPase domain of the membrane-integrated metalloprotease FtsH from Thermus thermophilus HB8.</article-title>
<source>Structure</source>
<volume>10</volume>
<fpage>1415</fpage>
<lpage>1423</lpage>
<pub-id pub-id-type="pmid">12377127</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Briggs1">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Briggs</surname><given-names>LC</given-names></name><name><surname>Baldwin</surname><given-names>GS</given-names></name><name><surname>Miyata</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>HS</given-names></name><name><surname>Zhang</surname><given-names>XD</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Analysis of nucleotide binding to p97 reveals the properties of a tandem AAA hexameric ATPase.</article-title>
<source>Journal of Biological Chemistry</source>
<volume>283</volume>
<fpage>13745</fpage>
<lpage>13752</lpage>
<pub-id pub-id-type="pmid">18332143</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Karata1">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karata</surname><given-names>K</given-names></name><name><surname>Inagawa</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>AJ</given-names></name><name><surname>Tatsuta</surname><given-names>T</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name></person-group>
<year>1999</year>
<article-title>Dissecting the role of a conserved motif (the second region of homology) in the AAA family of ATPases - Site-directed mutagenesis of the ATP-dependent protease FtsH.</article-title>
<source>Journal of Biological Chemistry</source>
<volume>274</volume>
<fpage>26225</fpage>
<lpage>26232</lpage>
<pub-id pub-id-type="pmid">10473576</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Suno1">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suno</surname><given-names>R</given-names></name><name><surname>Niwa</surname><given-names>H</given-names></name><name><surname>Tsuchiya</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Structure of the whole cytosolic region of ATP-dependent protease FtsH.</article-title>
<source>Molecular Cell</source>
<volume>22</volume>
<fpage>575</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">16762831</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Zhang1">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XD</given-names></name><name><surname>Wigley</surname><given-names>DB</given-names></name></person-group>
<year>2008</year>
<article-title>The âglutamate switchâ provides a link between ATPase activity and ligand binding in AAA plus proteins.</article-title>
<source>Nature Structural &amp; Molecular Biology</source>
<volume>15</volume>
<fpage>1223</fpage>
<lpage>1227</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Ogura1">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogura</surname><given-names>T</given-names></name><name><surname>Whiteheart</surname><given-names>SW</given-names></name><name><surname>Wilkinson</surname><given-names>AJ</given-names></name></person-group>
<year>2004</year>
<article-title>Conserved arginine residues implicated in ATP hydrolysis, nucleotide-sensing, and inter-subunit interactions in AAA and AAA(+) ATPases.</article-title>
<source>Journal of Structural Biology</source>
<volume>146</volume>
<fpage>106</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">15095758</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Ammelburg1">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ammelburg</surname><given-names>M</given-names></name><name><surname>Frickey</surname><given-names>T</given-names></name><name><surname>Lupas</surname><given-names>AN</given-names></name></person-group>
<year>2006</year>
<article-title>Classification of AAA+ proteins.</article-title>
<source>Journal of Structural Biology</source>
<volume>156</volume>
<fpage>2</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">16828312</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Holm1">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holm</surname><given-names>L</given-names></name><name><surname>Kaariainen</surname><given-names>S</given-names></name><name><surname>Rosenstrom</surname><given-names>P</given-names></name><name><surname>Schenkel</surname><given-names>A</given-names></name></person-group>
<year>2008</year>
<article-title>Searching protein structure databases with DaliLite v.3.</article-title>
<source>Bioinformatics</source>
<volume>24</volume>
<fpage>2780</fpage>
<lpage>2781</lpage>
<pub-id pub-id-type="pmid">18818215</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Bieniossek1">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bieniossek</surname><given-names>C</given-names></name><name><surname>Schalch</surname><given-names>T</given-names></name><name><surname>Bumann</surname><given-names>M</given-names></name><name><surname>Meister</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>R</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>The molecular architecture of the metalloprotease FtsH.</article-title>
<source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>103</volume>
<fpage>3066</fpage>
<lpage>3071</lpage>
<pub-id pub-id-type="pmid">16484367</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-YamadaInagawa1">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada-Inagawa</surname><given-names>T</given-names></name><name><surname>Okuno</surname><given-names>T</given-names></name><name><surname>Karata</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Ogura</surname><given-names>T</given-names></name></person-group>
<year>2003</year>
<article-title>Conserved pore residues in the AAA protease FtsH are important for proteolysis and its coupling to ATP hydrolysis.</article-title>
<source>Journal of Biological Chemistry</source>
<volume>278</volume>
<fpage>50182</fpage>
<lpage>50187</lpage>
<pub-id pub-id-type="pmid">14514680</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Martin1">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Baker</surname><given-names>AT</given-names></name><name><surname>Sauer</surname><given-names>AT</given-names></name></person-group>
<year>2008</year>
<article-title>Pore loops of the AAA+ ClpX machine grip substrates to drive translocation and unfolding.</article-title>
<source>Nature Structural &amp; Molecular Biology</source>
<volume>15</volume>
<fpage>1147</fpage>
<lpage>1151</lpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Brugman1">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugman</surname><given-names>F</given-names></name><name><surname>Scheffer</surname><given-names>H</given-names></name><name><surname>Wokke</surname><given-names>JHJ</given-names></name><name><surname>Nillesen</surname><given-names>WM</given-names></name><name><surname>de Visser</surname><given-names>M</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes.</article-title>
<source>Neurology</source>
<volume>71</volume>
<fpage>1500</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="pmid">18799786</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Wilkinson1">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>PA</given-names></name><name><surname>Crosby</surname><given-names>AH</given-names></name><name><surname>Turner</surname><given-names>C</given-names></name><name><surname>Bradley</surname><given-names>LJ</given-names></name><name><surname>Ginsberg</surname><given-names>L</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia.</article-title>
<source>Brain</source>
<volume>127</volume>
<fpage>973</fpage>
<lpage>980</lpage>
<pub-id pub-id-type="pmid">14985266</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Elleuch1">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elleuch</surname><given-names>N</given-names></name><name><surname>Depienne</surname><given-names>C</given-names></name><name><surname>Benomar</surname><given-names>A</given-names></name><name><surname>Hernandez</surname><given-names>AMO</given-names></name><name><surname>Ferrer</surname><given-names>X</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia.</article-title>
<source>Neurology</source>
<volume>66</volume>
<fpage>654</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="pmid">16534102</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Arnoldi1">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arnoldi</surname><given-names>A</given-names></name><name><surname>Tonelli</surname><given-names>A</given-names></name><name><surname>Crippa</surname><given-names>F</given-names></name><name><surname>Villani</surname><given-names>G</given-names></name><name><surname>Pacelli</surname><given-names>C</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia.</article-title>
<source>Human Mutation</source>
<volume>29</volume>
<fpage>522</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="pmid">18200586</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Ferreirinha1">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferreirinha</surname><given-names>F</given-names></name><name><surname>Quattrini</surname><given-names>A</given-names></name><name><surname>Valsecchi</surname><given-names>V</given-names></name><name><surname>Errico</surname><given-names>A</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Mice lacking paraplegin, a mitochondrial AAA protease involved in hereditary spastic paraplegia, show axonal degeneration and abnormal mitochondria.</article-title>
<source>American Journal of Human Genetics</source>
<volume>69</volume>
<fpage>103</fpage>
</element-citation>
      </ref>
      <ref id="pone.0006975-Atorino1">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atorino</surname><given-names>L</given-names></name><name><surname>Silvestri</surname><given-names>L</given-names></name><name><surname>Koppen</surname><given-names>M</given-names></name><name><surname>Cassina</surname><given-names>L</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Loss of m-AAA protease in mitochondria causes complex I deficiency and increases sensitivity to oxidative stress in hereditary spastic paraplegia.</article-title>
<source>Journal of Cell Biology</source>
<volume>163</volume>
<fpage>777</fpage>
<lpage>787</lpage>
<pub-id pub-id-type="pmid">14623864</pub-id></element-citation>
      </ref>
      <ref id="pone.0006975-Koppen1">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koppen</surname><given-names>M</given-names></name><name><surname>Metodiev</surname><given-names>MD</given-names></name><name><surname>Casari</surname><given-names>G</given-names></name><name><surname>Rugarli</surname><given-names>E</given-names></name><name><surname>Langer</surname><given-names>T</given-names></name></person-group>
<year>2007</year>
<article-title>Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia.</article-title>
<source>Molecular and Cellular Biology</source>
<volume>27</volume>
<fpage>758</fpage>
<lpage>767</lpage>
<pub-id pub-id-type="pmid">17101804</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>